Weekly News Recap #Phispers
US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations
Public health suffered several setbacks over the last week. First,
the United States formally exited the World Health Organiza...
Impressions : 1995
Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines
The New Year began with two mid-size deals centered around the use
of artificial intelligence (AI) in drug development. Sanofi...
Impressions : 1508
Sanofi gets two bids valuing its consumer unit at US$ 17 bn; Pfizer pulls SCD drug from market
In news this week, Sanofi is considering the sale of its consumer
health unit and has received binding bids valuing the divisi...
Impressions : 1512
IRA price talks conclude, three meds dominate savings; Gilead’s Livdelzi from CymaBay buyout gets FDA okay
This week, the Biden-Harris Administration said it has concluded price negotiations for 10 drugs under the Inflation Reduction ...
Impressions : 1120
Astra’s cancer drugs impress at ASCO; Moderna’s mRESVIA becomes first mRNA RSV vaccine approved by FDA
This week saw the American Society of Clinical Oncology (ASCO) annual meeting in Chicago where cancer researchers presented det...
Impressions : 1231
White House unveils plans to roll out jabs for 5 to 11 year olds; FDA authorizes Moderna, J&J boosters
This week, Phispers has more updates on Covid vaccines and boosters. Novavax’s Covid-19 vaccine program may have hit a br...
Impressions : 1746
Trump says Pfizer’s vaccine likely to be first Covid vaccine available; Dr Reddy’s settles blockbuster patent suit with BMS
This week, Phispers has lots of updates on experimental vaccines for Covid-19.
US President Donald Trump has said Pfizer coul...
Impressions : 51700
China to work with EU on aligning API standards; Lupin stumbles with FDA yet again
This week, Phispers has news from China, where its drug regulator said it would work with European Commission’s drug regu...
Impressions : 2230
Chinese plant littered with rodent feces supplied OTC products to US; Recipharm acquisition spree continues
In Phispers this week, we bring you news about US retailer Greenbrier International being issued an FDA warning letter for sour...
Impressions : 4095
AstraZeneca’s shareholders rebel over CEO pay; FDA lashes out at IQVIA over erroneous data
Soon after
US President Donald Trump revealed his new drug pricing plan, the FDA took a
tough stand by releasing a list of dr...
Impressions : 5181
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.